ResearcherUniversity of MichiganActive in the last 2 years
Deepak Nagrath
Matched on ORCID iD 0000-0002-8999-2282; OpenAlex author ID A5038715165; NIH RePORTER profile ID 10394394. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 2
- Labs led
- 1
- Collaborators
- 46
2017: 3 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 grant · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers, 1 grant
Papers 7
- Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Co-author DOI 10.1038/s41586-026-11134-x↗
- Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer. Co-author DOI 10.1038/s43018-026-01158-7↗
- Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours. Last author DOI 10.1038/s42255-020-0226-5↗
- Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Co-author DOI 10.7554/elife.50663↗
- Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Co-author DOI 10.1038/nature21052↗
- Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/ncomms14437↗
- The role of stromal cancer-associated fibroblasts in pancreatic cancer. Co-author DOI 10.1186/s13045-017-0448-5↗
Grants 2
Closest collaborators
The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Theodore Steven Lawrence · 1 shared paper, 1 shared grant, 2020–2026 · strength 1.09
- Sunitha Nagrath · 1 shared paper, 1 shared grant, 2020–2026 · strength 1.09
- Anirban Maitra · 5 shared papers, 2017–2026 · strength 0.50
- Paper Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/s41586-026-11134-x↗
- Paper The role of stromal cancer-associated fibroblasts in pancreatic cancer. DOI 10.1186/s13045-017-0448-5↗
- Paper Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours. DOI 10.1038/s42255-020-0226-5↗
- Lifeng Yang · 4 shared papers, 2017–2026 · strength 0.38
- Paper Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/s41586-026-11134-x↗
- Paper Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. DOI 10.7554/elife.50663↗
- Paper Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal aden… DOI 10.1038/ncomms14437↗
- Huamin Wang · 3 shared papers, 2017–2026 · strength 0.32
- Paper Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/s41586-026-11134-x↗
- Paper Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal aden… DOI 10.1038/ncomms14437↗
- Paper Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/nature21052↗
- Haoqiang Ying · 3 shared papers, 2017–2026 · strength 0.32
- Paper Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/s41586-026-11134-x↗
- Paper Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal aden… DOI 10.1038/ncomms14437↗
- Paper Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/nature21052↗
- Ronald Anthony Depinho · 3 shared papers, 2017–2026 · strength 0.32
- Paper Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/s41586-026-11134-x↗
- Paper Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal aden… DOI 10.1038/ncomms14437↗
- Paper Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/nature21052↗
- Vaibhav Sahai · 2 shared papers, 2020–2026 · strength 0.30
- Paper Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic… DOI 10.1038/s43018-026-01158-7↗
- Paper Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours. DOI 10.1038/s42255-020-0226-5↗
- Andrea Viale · 2 shared papers, 2017–2026 · strength 0.26
- Di Zhao · 2 shared papers, 2017–2026 · strength 0.26
- Ya’an Kang · 2 shared papers, 2017–2026 · strength 0.26
- Giannicola Genovese · 2 shared papers, 2017–2026 · strength 0.26
- Jason B. Fleming · 2 shared papers, 2017–2026 · strength 0.26
- Prasenjit Dey · 2 shared papers, 2017–2026 · strength 0.26
- Giulio Francesco Draetta · 2 shared papers, 2017–2026 · strength 0.26
- Tony Gutschner · 2 shared papers, 2017–2026 · strength 0.26
- Duxin Sun · 1 shared paper, 2026 · strength 0.22
- Lawrence H. Fong · 1 shared paper, 2026 · strength 0.22
- Christopher I. Li · 1 shared paper, 2026 · strength 0.22
- Dagny Von Ahrens · 2 shared papers, 2017–2019 · strength 0.15
- Tushar Damodar Bhagat · 2 shared papers, 2017–2019 · strength 0.15
- Amit K. Verma · 2 shared papers, 2017–2019 · strength 0.15
- Meredith Ann Morgan · 1 shared paper, 2020 · strength 0.09
- Sarah Owen · 1 shared paper, 2020 · strength 0.09
- Ziwen Zhu · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.